Alpha PSMA therapy is an innovative and targeted treatment approach that harnesses the power of alpha particles to combat prostate cancer. It is specifically designed for patients with metastatic castration-resistant prostate cancer (mCRPC) who have exhausted other treatment options.
The therapy revolves around the prostate-specific membrane antigen (PSMA), a protein found on the surface of prostate cancer cells. By using a radioactive substance called an alpha emitter, the treatment delivers highly potent alpha particles directly to the cancer cells, minimizing damage to healthy tissues.